Updated survival follow-up for phase I study of abexinostat with pazopanib in patients with solid tumor malignancies.-MedSci.cn

Updated survival follow-up for phase I study of abexinostat with pazopanib in patients with solid tumor malignancies.

Tsang, ES; Aggarwal, RR; Thomas, S; Dhawan, MS; Pawlowska, N; Bartelink, IH; Grabowsky, JA; Jahan, TM; Truong, TG; Ryan, CJ; Munster, PN

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务